Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1044355]Researchers: Dr Stephen Mattarollo (Principal investigator)
Brief description Patients with lymphoma cancers initially respond well to treatment, but later relapse with disease. The immune system can be effective at controlling cancer. A potential treatment option is to boost the natural immune response against cancer. This study investigates a vaccine that activates a certain immune cell, NKT cells, to fight lymphomas by delivering an NKT cell-activating molecule. Outcomes will allow assessment of combining an NKT-based vaccine with established treatments for lymphoma.
Funding Amount $AUD 451,606.61
Funding Scheme Project Grants
Notes New Investigator Grant
- nhmrc : 1044355
- PURL : https://purl.org/au-research/grants/nhmrc/1044355
